These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7974331)

  • 1. Impact of replacement therapy on the evolution of HIV infection in hemophiliacs.
    Berntorp E
    Thromb Haemost; 1994 Jun; 71(6):678-83. PubMed ID: 7974331
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of HIV-1 infection on CD4 cells in a hemophilia cohort.
    Green D; Deutsche J; Tang M; Goldsmith J
    Haematologica; 1990; 75 Suppl 5():132-41. PubMed ID: 1982277
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of factor VIII concentrates on the immune system of patients with hemophilia.
    Mannucci PM
    Thromb Haemost; 1995 Jul; 74(1):437-9. PubMed ID: 8578501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications of replacement therapy in hemophiliacs].
    Deguchi K; Kuto M; Morito T; Urata T
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):962-74. PubMed ID: 6984274
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates].
    Astermark J; Berntorp E; Stigendal L; Johnsson H
    Lakartidningen; 1998 Jan; 95(1-2):48-50. PubMed ID: 9458646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to acellular blood products and risk of HIV infection in hemophiliacs from Belo Horizonte, Brazil.
    Proietti FA; Proietti AB; Costa MF; Antunes CM; Guimarães MD; Paulino UH; Souza CJ; Melo L; Muñoz A
    Rev Inst Med Trop Sao Paulo; 1992; 34(3):227-32. PubMed ID: 1342075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Virus in hemophilia: current status and future perspectives].
    Aguilar C; Félix Lucía J
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV and Canada's hemophiliacs: looking back at a tragedy.
    Dunn K
    CMAJ; 1993 Feb; 148(4):609-12. PubMed ID: 8431823
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological investigation in hemophiliacs with and without human immunodeficiency virus (HIV) infection].
    Pang XG; Tang DJ
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):685-7, 729-30. PubMed ID: 1840032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction: replacement therapy for hemophilia: impact on the immune system.
    Aledort LM
    Semin Hematol; 1993 Oct; 30(4 Suppl 5):1. PubMed ID: 8266117
    [No Abstract]   [Full Text] [Related]  

  • 12. The acquired immunodeficiency syndrome in persons with hemophilia.
    Levine PH
    Ann Intern Med; 1985 Nov; 103(5):723-6. PubMed ID: 2996407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection in two brothers receiving intravenous therapy for hemophilia.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Apr; 41(14):228-31. PubMed ID: 1557013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed protocol for the evaluation of the effect of high purity factor concentrates on the immune system of hemophilia patients.
    Brettler DB
    Thromb Haemost; 1989 Sep; 62(2):811-2. PubMed ID: 2510353
    [No Abstract]   [Full Text] [Related]  

  • 15. Settlement accepted.
    AIDS Policy Law; 1996 Sep; 11(17):12. PubMed ID: 11363862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion. Argentina courts to try HIV-blood contamination cases.
    AIDS Policy Law; 2008 May; 23(6):8. PubMed ID: 18584800
    [No Abstract]   [Full Text] [Related]  

  • 17. Why prescribe highly purified factor VIII and IX concentrates?
    Berntorp E
    Vox Sang; 1996; 70(2):61-8. PubMed ID: 8801765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on children. The anxiety factor.
    Gregory M; Foy F
    Nurs Times; 1988 Apr 20-26; 84(16):71-2. PubMed ID: 3130616
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX.
    Lollar P
    J Thromb Haemost; 2004 Jul; 2(7):1082-95. PubMed ID: 15219191
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity and immune tolerance coagulation Factors VIII and IX.
    Rup B
    Dev Biol (Basel); 2003; 112():55-9. PubMed ID: 12762504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.